| |
RBM3 staining intensity
|
|---|
| |
0-2
|
3
| |
|---|
|
n(%)
|
95 (44.2)
|
120 (55.8)
|
p-value
|
|---|
|
Age
| | | |
|
Mean
|
68.00
|
67.15
|
0.673
|
|
(range)
|
(47-83)
|
(46-81)
| |
|
Gender
| | | |
|
Female
|
45(47.4)
|
63(52.5)
|
0.457
|
|
Male
|
50(52.6)
|
57(47.5)
| |
|
Clark level
| | | |
|
II
|
21(22.3)
|
50(42.4)
|
0.005**
|
|
IIII
|
48(51.1)
|
46(39.0)
| |
|
IV-V
|
25(26.6)
|
22(18.6)
| |
|
missing
|
1
|
2
| |
|
Breslow(mm)
| | | |
|
Mean
|
2.47
|
1.12
|
0.001**
|
|
(range)
|
(0.08-40.00)
|
(0.11-7.00)
| |
|
Ulceration
| | | |
|
No
|
71(74.7)
|
109(91.6)
|
0.001**
|
|
Yes
|
24(25.3)
|
10(8.4)
| |
|
missing
|
0
|
1
| |
|
Lymphocytic
| | | |
|
infiltrate
| | | |
|
0-1
|
26(27.4)
|
34(28.6)
|
0.846
|
|
2-3
|
69(72.6)
|
85(71.4)
| |
|
missing
|
0
|
1
| |
|
Clinical stage
| | | |
|
I
|
54(76.1)
|
95(91.3)
|
0.005*
|
|
II-IV
|
17(23.9)
|
9(8.7)
| |
|
missing
|
24
|
16
| |
|
Vascular invasion
| | | |
|
No
|
87(91.6)
|
114(95.0)
|
0.314
|
|
Yes
|
8(8.4)
|
6(5.0)
| |
|
Localization
| | | |
|
Head and neck
|
15(16.0)
|
16(14.0)
|
0.352
|
|
Extremities
|
40(42.6)
|
59(51.8)
| |
|
Frontal thorax
|
10(10.6)
|
15(13.2)
| |
|
Dorsal thorax
|
29(30.9)
|
24(21.1)
| |
|
missing
|
1
|
6
| |
|
Type
| | | |
|
SSM, LMM, Other
|
65(58.9)
|
97(68.9)
|
0.027*
|
|
NMM
|
30(31.6)
|
22(18.5)
| |
|
missing
|
0
|
1
| |
|
Mitotic count
| | | |
|
< 1/mm2
|
34(35.8)
|
71(59.2)
|
0.001**
|
|
> = 1/mm2
|
61(64.2)
|
49(40.8)
| |
- *Significant at the 0.05 level
- ** Significant at the 0.01 level
- § Mann Whitney U test for comparison of means
- SSM = Superficial spreading melanoma
- NMM = Nodular malignant melanoma
- LMM = Lentigo malignant melanoma
